Background. Recent trials of prenatal multivitaminmineral supplements have yielded mixed findings for outcomes such as birth size, but the benefits of prenatal multivitamin-mineral supplements for maternal outcomes are unknown.
Introduction
Poor maternal nutrition both before and during pregnancy is an important cause of poor pregnancy outcomes, especially in developing countries [1, 2] . Weight gain during pregnancy is widely used as an indicator of the adequacy of nutrition during pregnancy and has been associated with infant outcomes such as mortality, prematurity, and low birthweight [1, 3] . Studies have shown that while weight gain in healthy populations, such as the United States, averages around 12.5 kg, weight gain is only 7 to 8 kg in many developing countries [4] . Several intervention trials have been conducted to evaluate the benefits of increasing food intakes during pregnancy on maternal and infant outcomes, but the findings have varied either by the type of outcome examined or study setting [2] . Although improved birth outcomes such as higher birthweight are usually accompanied by increased maternal weight gain and/or body fat, this has not always been the case [5, 6] ; further documentation of the impact of improved nutrition during pregnancy on maternal outcomes in addition to birth outcomes is necessary.
Improved micronutrient intakes during pregnancy may contribute to increased energy intakes by influencing appetite [7] . Although several intervention trials have been conducted using either food supplements or single nutrients such as vitamin A or zinc, few have examined the impact of prenatal multivitamin Effect of prenatal multiple micronutrient supplements on maternal weight and skinfold changes: Effect of prenatal multiple micronutrient supplements on maternal weight and skinfold changes:
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Usha Ramakrishnan Mention of the names of firms and commercial products does not imply endorsement by the United Nations University. Usha Ramakrishnan, Teresa González-Cossío, Lynnette Marie Neufeld, Juan Rivera, and Reynaldo Martorell mineral supplements (MVMS), an approach that is being considered by many international agencies as a simpler strategy to improve pregnancy outcomes. Two observational studies in the US have shown that routine consumption of MVMS supplements was associated with increased weight gain during pregnancy and improved birth outcomes (low birthweight and preterm deliveries) even after controlling for differences in factors such as access to prenatal care and baseline nutritional status [8, 9] . In one intervention trial, multivitamin supplements reduced the incidence of prematurity and low birthweight by about 40% compared to routine iron-folate (FE-folate) supplements [10] , and also improved maternal T-cell counts and weight gain during pregnancy in HIV-positive asymptomatic women [11] .
The benefit of multiple micronutrient (MM) supplements for non-HIV infected women, however, is not known. In Nepal [12] , MVMS did not improve birth outcomes when compared to FE-folate supplements (regarded as a standard of care), but the impact on maternal outcomes was not reported. We recently conducted a randomized, double-blind controlled trial in semi-rural Mexico to compare the efficacy of a multiple micronutrient (MM) supplement compared to an iron-only (FE) supplement during pregnancy in improving maternal and infant outcomes. In a previous publication, we reported that MM supplements did not improve birth weight or length compared to iron-only supplements [13] . Mean birth weight was 2.981 and 2.977 kg in the MM and FE groups, respectively. The specific outcomes examined in this paper are weight gain and changes in maternal anthropometry both during pregnancy and at 1 month postpartum.
Methods

Study setting and design
This study was a collaborative project between the Rollins School of Public Health, Emory University, Atlanta Ga, USA, and the Centro de Investigación en Nutrición y Salud, Instituto Nacional de Salud Pública (INSP), Cuernavaca, Mexico. The study site was a semi-rural community, near the city of Cuernavaca, in Morelos, Mexico. We used a randomized double-blind design in which the treatment group received the MM supplement containing 1 to 1.5 RDA (Recommended Dietary Allowance) of key vitamins (A, D, E, B 1 , B 2 , B 3 , B 6 , B 12 , C, and folic acid) and minerals (Zn, Mg), and 60 mg of iron. The control group received 60 mg iron, which was the standard practice of the Ministry of Health in Mexico at the time the study was conducted.
The study protocol was approved by the Human Investigations Committee at Emory University and at INSP, and written informed consent was obtained from all eligible subjects at recruitment. We excluded women who were more than 13 weeks pregnant at recruitment or who reported the use of micronutrient supplements (n = 8). All eligible pregnancies were randomly allocated to either the MM or FE group using four color-coded groups (two per treatment) assigned a priori using a computer-generated list. Participants were visited at their homes six days a week by trained workers who administered and recorded the consumption of supplements until delivery. All study personnel and investigators were blinded to group assignment, the details of which were kept in sealed envelopes in both institutions and opened only after preliminary data analysis was completed. Additional details of the supplement composition and of recruitment and treatment allocation are provided elsewhere [13] .
Data collection
At recruitment, which began in July 1997, all participants were provided with a prenatal examination that included a detailed obstetric history, physical examination, anthropometric and dietary assessments, and blood draw. All examinations and assessments were carried out by the study physician and a team of trained nurses at the study headquarters. Height, weight, mid upper arm circumference (MUAC), tricep skinfold (TSF), and subscapular skinfold (SSF) thicknesses were measured several times by workers trained in standard anthropometric techniques [14] . All subjects were asked to come to the study headquarters for routine prenatal care visits at 26, 32, and 37 weeks of pregnancy. An additional exam was conducted in each participant's home at one month postpartum, during which anthropometric measurements were taken again. Due to budgetary limitations, a modified protocol was implemented after September 1, 1999, from which point only weight was measured at the 32-and 37week prenatal visits. Socioeconomic status (SES) was determined using a questionnaire that included details of education, ethnicity, water and sanitation, quality of housing, household size, occupation, and possessions such as a television set, radio, or bicycle. An index of economic status was derived from these data using factor analysis [15] .
Data analysis
The main outcome variables were maternal weight gain and changes in MUAC, TSF, and SSF from recruitment to 37 weeks pregnancy and from recruitment to 1 month postpartum. We also examined early (recruitment to 26 weeks pregnancy) and late weight gain (26 weeks to 37 weeks pregnancy) and defined inadequate weight gain during pregnancy as weekly weight gain below 225 g/week.
Using an intent-to-treat design, all pregnancies assigned to treatment between July 1997 and December 31, 1999 were included and the effectiveness of randomization was tested by comparing the two groups for selected sociodemographic, health, and nutrition characteristics of the women at recruitment. Comparisons between the final sample with information on maternal weight gain and changes in anthropometry and those participants lost to follow-up were also done for selected baseline characteristics and for measures of compliance (defined as the proportion of supplements consumed while in the study). All comparisons were done using Student's t-tests for normally distributed variables and chi-square tests of proportions for categorical variables. The analysis was restricted to pregnancies that resulted in singleton term live births and had data available on the outcomes of interest. Following unadjusted comparisons of key outcomes by intervention group, adjusted analyses using multivariate techniques (general linear models) were done to control for maternal body-mass index (BMI) and marital status, both of which differed significantly between groups at recruitment. In addition, effect modification by characteristics selected a priori (maternal overweight at recruitment and economic status) was tested. Overweight was defined using the World Health Organization (WHO) definition of BMI ≥ 25 kg/m 2 [16] . All statistical analyses were conducted using SAS 8.2 (SAS Institute, Cary, NC, USA). Since some women contributed more than one pregnancy to the study, repeated measures analysis (SAS PROC MIXED) were used to compare the main outcomes of interest. Statistical significance was based on the criterion of p < .05 for simple group differences and p < 0.15 for tests of interactions.
Results
A total of 921 pregnancies were identified and 873 were assigned to treatment-435 to the multiple micronutrient group and 438 to the iron group. Details of birth outcomes and reasons for loss to follow-up have been described elsewhere [13] . The comparison of selected maternal characteristics at recruitment (table 1) showed that the two groups were similar for the majority of characteristics, including maternal age at recruitment, number of weeks pregnant at entry, percent primiparous, years of schooling, economic status, and percent anemic. There were also no differences in reported energy and micronutrient intakes between intervention groups at baseline (results not shown). However, the proportion of single mothers was higher in the MM group compared to the FE group, although a majority of women in both groups had a partner. Additionally, although mean height was similar between the groups, women in the FE group were significantly heavier (p < .05) compared to those in the MM group as demonstrated by greater weight, BMI, and skinfold measurements; almost a third were overweight with a higher proportion in the FE group (38.7%), compared to the MM group (30.8%).
Out of the final sample of 602 pregnancies that resulted in singleton term live births, maternal weights were available at recruitment and 37 weeks' gestation for 570 pregnancies (502 women), and at recruitment and 1 month postpartum for 577 pregnancies (505 women). Approximately 14% of women contributed more than one pregnancy to the study. Mean birth weight was 3.1 kg with no group differences. The complete battery of anthropometric variables was available for a smaller subsample at 37 weeks' gestation (n = 371) and 1 month postpartum (n = 456), as only weight was measured after September 1999. Women for whom data on weight gain during pregnancy were available were younger (p < .05) compared to those without available data, and the subsamples with full anthropometry had a lower hemoglobin concentration (p < .05) compared to those without these data. However, there were no differences in anthropometric measurements at recruitment for all subsamples.
The mean values for the changes in weight and other anthropometric measurements from recruitment to 37 weeks' gestation and 1 month postpartum are presented by intervention group in table 2. Weight gain during pregnancy was lower than recommended in both groups [4] , approximately 7-8 kg from recruitment to 37 weeks. Although mean weight gain was about 0.6 kg greater for the MM group, these differences were attenuated to 0.32 kg and ceased to be statistically significant (p = .24) after adjusting for baseline differences in BMI. The findings were similar for differences in weekly weight gain (270 g/week). The incidence of low weight gain was lower in the MM group (34.1%) compared to the FE group (40.1%), but these differences (odds ratio: 0.75; 95% confidence interval [CI]: 0.54, 1.06) were also attenuated after adjusting for baseline differences in BMI (adjusted odds ratio: 0.89; 95% CI: 0.62, 1.28). Women retained about 2 kg from the time of recruitment to 1 month postpartum; although this was greater for the MM group (0.71 kg), these differences were also attenuated (0.33 kg) and not significantly different after adjusting for baseline differences in BMI. There were no significant differences in changes in MUAC, TSF, and SSF between the experimental groups. Restricting the analysis to women who contributed only one pregnancy did not alter these findings.
The comparison of the pattern of weight gain during pregnancy by intervention group (table 3) also did not reveal any significant differences after adjusting for baseline differences. Weight gain from recruitment to 26 weeks' pregnancy was higher in the MM group compared to the FE group in terms of actual weight gained and rate of weekly gain, but these differences were attenuated and not statistically significant after adjusting for baseline differences in BMI. In contrast, weight gain during late pregnancy i.e., from 26 weeks to 37 weeks of pregnancy was similar in both groups, suggesting that the differences seen in overall weight gain before adjustment occurred in the first half of pregnancy.
There were no interactions for changes in anthropometry and weight during pregnancy and from , in contrast to non-overweight women, who retained about 3 kg in both groups (p = .7). The reductions in MUAC, TSF, and SSF thickness from recruitment to 1 month postpartum among overweight women were less in the MM group when compared to the FE group (p = .06, p = .12, and p = .07, respectively), with no differences by treatment group among non-overweight women (p > .25). It should also be noted that these interactions remained significant (p < .05 for changes from recruitment to 1-month postpartum) when restricted to the sample of women who contributed only one pregnancy.
Discussion
The absence of an effect of the intervention on maternal weight gain and changes in anthropometry during pregnancy as well as from recruitment to 1-month postpartum following adjustments for baseline differences in BMI are consistent with our earlier findings of no improvements in birth size [13] . These results are not affected by inadequate sample size for most of the outcomes. Power calculations indicate that our study sample had at least 80% power to detect a difference of 0.6 kg between the two groups for both weight gain during pregnancy and changes from recruitment to 1 month postpartum, assuming a two-tailed test and significance level of .05 [17] . Similar calculations also revealed that we had at least 80% power to detect a difference of 0.5 cm and 1 mm for changes in MUAC and skinfold thickness during pregnancy (n = 371) and from recruitment to 1 month postpartum (n = 456) except for changes in TSF during pregnancy (power = 0.64 and 0.74 for a two-and one-tailed test, respectively). It should be noted that the above differences represent small to medium effect sizes (0.2-0.35 SD). The observed changes in body composition were also small and the mean values in both treatment groups fell within the normal distribution of values for Caucasian women of comparable age measured in the first and second National Health and Examination Surveys (NHANES) in the United States [18] .
Furthermore, there appears to be no selection bias that may explain these findings. Baseline anthropometric measurements were similar in the final samples when compared to the original sample of all pregnancies recruited in the trial. The comparison of baseline characteristics by intervention group in the final subsamples (data not shown) was also similar to those presented for the original sample (table 1) . Finally, although we had to exclude preterm births (n = 43) as they precluded measurements at 37 weeks, we found similar findings when we examined weight gain during early pregnancy for the larger sample (n = 664) and included preterm births in the analysis of outcomes from recruitment to 1-month postpartum (data not shown).
It is also important to note that the lack of effect occurred in the context of lower-than-recommended weight gains (mean = 12 kg) and cannot be attributed to a ceiling effect [4] . Although there is less information on changes in body composition [19] , overall weight gain in this study is similar to those reported in populations from developing countries [1, 4, 20, 21] . Recent findings from a longitudinal prospective study in Guatemala using similar protocols show mean weight gain during pregnancy of approximately 7 kg [22] .
Although several observational studies and food supplementation trials have examined maternal outcomes such as weight gain during pregnancy [2, 23] , there is very little information as to the role of micronutrients. Villamor et al. [11] reported that average weight gain (306 g/week) was significantly higher during the third trimester in the group of HIV-positive women who received prenatal multivitamins compared to those who received the placebo. These same researchers also reported that the risk of low weight gain (< 100 g/wk) was also significantly lower (~30%) in the intervention group [11] , which is consistent with their previously reported results of reductions in the incidence of low birth weight [10] . However, the relevance of these findings to non-HIV infected populations is unclear. Among studies conducted in non-HIV infected populations, a prospective study of young African-American women by Scholl et al. [8] found that the proportion of women with inadequate weight gain (28.7%) was significantly higher among women who did not report consuming prenatal MVMS compared to those who did (22%). Similarly, in an earlier supplementation trial from Chile [24] , women who consumed a fortified milk supplement had significantly higher weight gain (12.3 kg) compared to those who received the unfortified supplement (11.5 kg). Improved birth outcomes were reported in both these studies.
The change in weight from recruitment to 1 month postpartum is consistent with studies in well-nourished populations showing that postpartum weight retention ranges from none to 2 kg per pregnancy [25] . This is in contrast to overall weight loss, i.e., "maternal depletion syndrome" common in populations with moderate to severe chronic energy deficiency [26, 27] . Pregnancy-related weight retention is of increasing concern in populations such as the United States, where overweight and obesity are significant public health problems. Recent data from the National Nutrition Survey in Mexico also indicate that overweight and obesity are emerging public health problems that need to be addressed along with undernutrition [28] . Therefore, our finding that overweight women who received MM retained more weight compared to those who received only iron may be of concern. It is important to note that these women gained only about 6 kg during pregnancy, with little or no weight retention postpartum. These weight gains are comparable to the recommendations for overweight women in the United States [4] and it would therefore be important to determine if the observed differences are transient or not. Ongoing follow-up studies of these women will provide valuable information. Similarly, although the differences in MUAC and SSF measurements suggest that there may be increased retention of body fat stores in the MM group, there were decreases in MUAC and SSF in overweight women in both supplement groups. It should also be noted that our findings were not affected by the exclusion of preterm births, as we had similar findings. Although few intervention trials have examined changes in maternal body composition, observational studies primarily from the United States have shown that higher gestational weight gain, African-American race, younger age and low socioeconomic status have been positively associated with increased pregnancy-related weight retention [25] , whereas prepregnancy BMI was negatively associated with overall weight gain [4] as well as fat gain during pregnancy [29] .
In summary, our findings indicate that compared to iron supplements, MM supplements do not affect weight gain during pregnancy, but may lead to greater postpartum weight retention and smaller decreases in MUAC and skinfold thickness among overweight women. It should, however, be noted that while p values < .15 or even < .20 are recommended for tests of interactions, some may call for more stringent criteria, i.e., p < .05, and that there is a need to confirm these findings. Further work that examines whether these differences are explained by changes in dietary intakes during pregnancy will also be useful in understanding potential mechanisms, as well in determining if there are other benefits such as improved quality of breast milk in terms of micronutrient content and infant growth and development.
